π¨ BREAKING Scientists just gave 15 people a single IV drip.
No daily pills.
No monthly injections.
One time.
Done.
Their "bad" cholesterol dropped 50%.
Triglycerides dropped 55%.
And it may be PERMANENT.
This is CRISPR β and it just changed cardiology forever. π§΅
No daily pills.
No monthly injections.
One time.
Done.
Their "bad" cholesterol dropped 50%.
Triglycerides dropped 55%.
And it may be PERMANENT.
This is CRISPR β and it just changed cardiology forever. π§΅
The drug is called CTX310.
It's made by CRISPR Therapeutics.
Here's how it works in plain English:
Your liver makes a protein called ANGPTL3.
That protein BLOCKS your body from clearing cholesterol.
CTX310 turns that gene OFF.
Permanently.
Like flipping a switch β and never having to flip it again. π¬
It's made by CRISPR Therapeutics.
Here's how it works in plain English:
Your liver makes a protein called ANGPTL3.
That protein BLOCKS your body from clearing cholesterol.
CTX310 turns that gene OFF.
Permanently.
Like flipping a switch β and never having to flip it again. π¬
Here's the wild part.
Some people are BORN with a broken ANGPTL3 gene.
What happens to them?
β Lifelong low cholesterol
β Lifelong low triglycerides
β Dramatically lower heart disease risk
β No harmful side effects
Scientists thought: what if we could give EVERYONE that mutation?
That's exactly what CTX310 does. π§¬
Some people are BORN with a broken ANGPTL3 gene.
What happens to them?
β Lifelong low cholesterol
β Lifelong low triglycerides
β Dramatically lower heart disease risk
β No harmful side effects
Scientists thought: what if we could give EVERYONE that mutation?
That's exactly what CTX310 does. π§¬
The clinical trial results were published in the New England Journal of Medicine.
15 patients.
All had cholesterol disorders that DIDN'T respond to standard drugs.
After ONE infusion:
π LDL cholesterol: DOWN 49% (max -87%)
π Triglycerides: DOWN 55% (max -84%)
π ANGPTL3 protein: DOWN 73% (max -89%)
Effects kicked in within 2 WEEKS.
Still holding at 60 days follow-up.
15 patients.
All had cholesterol disorders that DIDN'T respond to standard drugs.
After ONE infusion:
π LDL cholesterol: DOWN 49% (max -87%)
π Triglycerides: DOWN 55% (max -84%)
π ANGPTL3 protein: DOWN 73% (max -89%)
Effects kicked in within 2 WEEKS.
Still holding at 60 days follow-up.
How does CRISPR even get INTO your liver cells?
The secret: Lipid Nanoparticles (LNPs).
Tiny fat bubbles β the same tech used in mRNA COVID vaccines.
They carry the CRISPR editing tools directly to liver cells.
Once inside:
β’ Cas9 enzyme cuts the ANGPTL3 gene
β’ The cell tries to repair the cut
β’ The repair breaks the gene β permanently
One infusion.
Done.
The liver keeps the edit for life.
The secret: Lipid Nanoparticles (LNPs).
Tiny fat bubbles β the same tech used in mRNA COVID vaccines.
They carry the CRISPR editing tools directly to liver cells.
Once inside:
β’ Cas9 enzyme cuts the ANGPTL3 gene
β’ The cell tries to repair the cut
β’ The repair breaks the gene β permanently
One infusion.
Done.
The liver keeps the edit for life.
Let me put this in perspective.
Current cholesterol treatments:
π Statins β Take EVERY DAY
π PCSK9 injections β Every 2β4 WEEKS
π Inclisiran β Twice a YEAR
CTX310: π Once.
Possibly FOREVER.
And it's the ONLY treatment that simultaneously drops both LDL AND triglycerides in one shot.
Nothing else does that.
Current cholesterol treatments:
π Statins β Take EVERY DAY
π PCSK9 injections β Every 2β4 WEEKS
π Inclisiran β Twice a YEAR
CTX310: π Once.
Possibly FOREVER.
And it's the ONLY treatment that simultaneously drops both LDL AND triglycerides in one shot.
Nothing else does that.
Now β let's talk about safety. Because this matters.
The honest picture:
β No treatment-related serious adverse events
β No dangerous liver enzyme spikes
β No dose-limiting toxicities
β οΈ 3 patients had minor infusion reactions (nausea, back pain) β resolved quickly
β οΈ 1 patient had a brief liver enzyme bump β back to normal in 14 days
2 serious events occurred β but BOTH were ruled unrelated to CTX310. Early data. Promising. But more study is needed.
The honest picture:
β No treatment-related serious adverse events
β No dangerous liver enzyme spikes
β No dose-limiting toxicities
β οΈ 3 patients had minor infusion reactions (nausea, back pain) β resolved quickly
β οΈ 1 patient had a brief liver enzyme bump β back to normal in 14 days
2 serious events occurred β but BOTH were ruled unrelated to CTX310. Early data. Promising. But more study is needed.
Here's what nobody is talking about enough.
The FDA requires 15 YEARS of safety follow-up for all CRISPR gene therapies.
Why?
Because editing DNA is irreversible.
If something goes wrong β you can't un-edit a gene.
We don't know:
β Will the effect last 10, 20, 30 years?
β Could there be off-target DNA edits?
β Long-term cancer risk?
This is why Phase 2 & 3 trials matter enormously.
The FDA requires 15 YEARS of safety follow-up for all CRISPR gene therapies.
Why?
Because editing DNA is irreversible.
If something goes wrong β you can't un-edit a gene.
We don't know:
β Will the effect last 10, 20, 30 years?
β Could there be off-target DNA edits?
β Long-term cancer risk?
This is why Phase 2 & 3 trials matter enormously.
Who is this designed for right now?
The Phase 1 trial enrolled:
π΄ Homozygous Familial Hypercholesterolemia β inherited extreme high LDL
π΄ Severe Hypertriglyceridemia β dangerously high triglycerides
π΄ Mixed Dyslipidemia β both LDL AND triglycerides elevated
π΄ All had FAILED standard treatments
40+ million Americans have elevated LDL, high triglycerides, or both.
If this scales β the potential is enormous.
The Phase 1 trial enrolled:
π΄ Homozygous Familial Hypercholesterolemia β inherited extreme high LDL
π΄ Severe Hypertriglyceridemia β dangerously high triglycerides
π΄ Mixed Dyslipidemia β both LDL AND triglycerides elevated
π΄ All had FAILED standard treatments
40+ million Americans have elevated LDL, high triglycerides, or both.
If this scales β the potential is enormous.
So what happens next?
π Phase 1b trials:
NOW ENROLLING β Focused on severe hypertriglyceridemia + mixed dyslipidemia
β Larger groups, longer follow-up π
Phase 2 trials: Expected ~late 2026 π
Hard outcomes trials (heart attacks? strokes? mortality?) β Years away. T
his isn't a treatment you can get yet. But the door just opened in a way it never has before.
Watch ClinicalTrials.gov for updates. π
π Phase 1b trials:
NOW ENROLLING β Focused on severe hypertriglyceridemia + mixed dyslipidemia
β Larger groups, longer follow-up π
Phase 2 trials: Expected ~late 2026 π
Hard outcomes trials (heart attacks? strokes? mortality?) β Years away. T
his isn't a treatment you can get yet. But the door just opened in a way it never has before.
Watch ClinicalTrials.gov for updates. π
Step back and think about what this really means.
CRISPR was supposed to be for rare diseases.
Sickle cell.
Muscular dystrophy.
One in a million.
Now it's targeting the #1 killer of humans on earth β¦ Heart disease.
If CTX310 works in large trials β we're not talking about treating millions.
We're talking about potentially PREVENTING heart disease with a single infusion.
The science fiction future just got a lot closer.
CRISPR was supposed to be for rare diseases.
Sickle cell.
Muscular dystrophy.
One in a million.
Now it's targeting the #1 killer of humans on earth β¦ Heart disease.
If CTX310 works in large trials β we're not talking about treating millions.
We're talking about potentially PREVENTING heart disease with a single infusion.
The science fiction future just got a lot closer.
If you found this thread valuable:
β»οΈ Retweet the first tweet β someone you know needs to see this
β€οΈ Follow for more medical breakthroughs explained simply
π Bookmark this thread β this story is just getting started
β οΈ IMPORTANT: CTX310 is NOT available yet.
It's investigational.
Talk to a cardiologist about YOUR cholesterol options TODAY.
Screenshots to the actual peer-reviewed trial and all sources in this thread. π¬π§¬
β»οΈ Retweet the first tweet β someone you know needs to see this
β€οΈ Follow for more medical breakthroughs explained simply
π Bookmark this thread β this story is just getting started
β οΈ IMPORTANT: CTX310 is NOT available yet.
It's investigational.
Talk to a cardiologist about YOUR cholesterol options TODAY.
Screenshots to the actual peer-reviewed trial and all sources in this thread. π¬π§¬
β’ β’ β’
Missing some Tweet in this thread? You can try to
force a refresh
γ
